American Portfolios Advisors’s Viking Therapeutics VKTX Stock Holding History

American Portfolios Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5.44K	Hold	2,000	–	–	﹤0.01%	2787
2022 Q2	$5.78K	Hold	2,000	–	–	﹤0.01%	2777
2022 Q1	$6K	Hold	2,000	–	–	﹤0.01%	2877
2021 Q4	$9.2K	Hold	2,000	–	–	﹤0.01%	2652
2021 Q3	$12.6K	Hold	2,000	–	–	﹤0.01%	2468
2021 Q2	$12K	Hold	2,000	–	–	﹤0.01%	2436
2021 Q1	$12.7K	Hold	2,000	–	–	﹤0.01%	2274
2020 Q4	$11.3K	Sell	2,000 -275	-12%	-$1.67K	﹤0.01%	2057
2020 Q3	$13.2K	Sell	2,275 -19	-0.8%	-$131	﹤0.01%	1866
2020 Q2	$16.5K	Buy	2,294 +1,394	+155%	+$9.26K	﹤0.01%	1721
2020 Q1	$4.21K	Hold	900	–	–	﹤0.01%	2163
2019 Q4	$7.22K	Hold	900	–	–	﹤0.01%	2134
2019 Q3	$6.19K	Hold	900	–	–	﹤0.01%	2112
2019 Q2	$7.47K	Hold	900	–	–	﹤0.01%	2020
2019 Q1	$8.95K	Buy	+900	New	+$7.53K	﹤0.01%	1872

Other funds holding VKTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Portfolios Advisors's VKTX Position: Q3 2022 in Review

American Portfolios Advisors held its Viking Therapeutics (VKTX) position steady in Q3 2022 at 2,000 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2787.

American Portfolios Advisors first reported a position in VKTX in Q1 2019 and has held it in 15 quarters since. The position peaked at $16.5K in Q2 2020. 107 funds tracked by Wall St. Rank hold VKTX as of Q3 2022.

American Portfolios Advisors held 2,000 shares of Viking Therapeutics worth $5.44K as of Q3 2022.
American Portfolios Advisors left its Viking Therapeutics share count unchanged in Q3 2022.
Viking Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2787 holding.
American Portfolios Advisors first reported a position in Viking Therapeutics in Q1 2019 and has held it in 15 quarters since.
American Portfolios Advisors's Viking Therapeutics position peaked at $16.5K in Q2 2020.
107 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.